Impact of the COVID-19 Pandemic on Prescription Drug Use and Costs in British Columbia: a Retrospective Interrupted Time Series Study

Overview

Journal BMJ Open

Specialty General Medicine

Date 2024 Jan 4

PMID 38176877

Authors

Seraphine Zeitouny

Kimberlyn McGrail

Mina Tadrous

Sabrina T Wong

Lucy Cheng

Michael Law

Affiliations

Soon will be listed here.

Abstract

Objectives: To assess the impact of the COVID-19 pandemic on prescription drug use and costs.

Design: Interrupted time series analysis of comprehensive administrative health data linkages in British Columbia, Canada, from 1 January 2018 to 28 March 2021.

Setting: Retrospective population-based analysis of all prescription drugs dispensed in community pharmacies and outpatient hospital pharmacies and irrespective of the drug insurance payer.

Participants: Between 4.30 and 4.37 million individuals (52% women) actively registered with the publicly funded medical services plan.

Intervention: COVID-19 pandemic and associated mitigation measures.

Main Outcome Measures: Weekly dispensing rates and costs, both overall and stratified by therapeutic groups and pharmacological subgroups, before and after the declaration of the public health emergency related to the COVID-19 pandemic. Relative changes in post-COVID-19 outcomes were expressed as ratios of observed to expected rates.

Results: After the onset of the pandemic and subsequent COVID-19 mitigation measures, overall medication dispensing rates dropped by 2.4% (p<0.01), followed by a sustained weekly increase to return to predicted levels by the end of January 2021. We observed abrupt level decreases in antibacterials (30.3%, p<0.01) and antivirals (22.4%, p<0.01) that remained below counterfactuals over the first year of the pandemic. In contrast, there was a week-to-week trend increase in nervous system drugs, yielding an overall increase of 7.3% (p<0.01). No trend changes in the dispensing of respiratory system agents, ACE inhibitors, antidiabetic drugs and antidepressants were detected.

Conclusion: The COVID-19 pandemic impact on prescription drug dispensing was heterogeneous across medication subgroups. As data become available, dispensing trends in nervous system agents, antibiotics and antivirals warrant further monitoring and investigation.

References

Kitano T, Brown K, Daneman N, MacFadden D, Langford B, Leung V . The Impact of COVID-19 on Outpatient Antibiotic Prescriptions in Ontario, Canada; An Interrupted Time Series Analysis. Open Forum Infect Dis. 2021; 8(11):ofab533. PMC: 8601042. DOI: 10.1093/ofid/ofab533. View

Sansone R, Sansone L . Antidepressant adherence: are patients taking their medications?. Innov Clin Neurosci. 2012; 9(5-6):41-6. PMC: 3398686. View

Baker R, Park S, Yang W, Vecchi G, Metcalf C, Grenfell B . The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020; 117(48):30547-30553. PMC: 7720203. DOI: 10.1073/pnas.2013182117. View

Law M, Morgan S, Majumdar S, Lynd L, Marra C . Effects of prescription adaptation by pharmacists. BMC Health Serv Res. 2010; 10:313. PMC: 2994856. DOI: 10.1186/1472-6963-10-313. View

Wagner A, Soumerai S, Zhang F, Ross-Degnan D . Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002; 27(4):299-309. DOI: 10.1046/j.1365-2710.2002.00430.x. View

Detsky A, Bogoch I . COVID-19 in Canada: Experience and Response. JAMA. 2020; 324(8):743-744. DOI: 10.1001/jama.2020.14033. View

Milani S, Raji M, Chen L, Kuo Y . Trends in the Use of Benzodiazepines, Z-Hypnotics, and Serotonergic Drugs Among US Women and Men Before and During the COVID-19 Pandemic. JAMA Netw Open. 2021; 4(10):e2131012. PMC: 8546497. DOI: 10.1001/jamanetworkopen.2021.31012. View

Palis H, Belair M, Hu K, Tu A, Buxton J, Slaunwhite A . Overdose deaths and the COVID-19 pandemic in British Columbia, Canada. Drug Alcohol Rev. 2021; 41(4):912-917. DOI: 10.1111/dar.13424. View

Hirschtritt M, Slama N, Sterling S, Olfson M, Iturralde E . Psychotropic medication prescribing during the COVID-19 pandemic. Medicine (Baltimore). 2021; 100(43):e27664. PMC: 8556031. DOI: 10.1097/MD.0000000000027664. View

10.

Uthayakumar S, Tadrous M, Vigod S, Kitchen S, Gomes T . The effects of COVID-19 on the dispensing rates of antidepressants and benzodiazepines in Canada. Depress Anxiety. 2021; 39(2):156-162. PMC: 9015529. DOI: 10.1002/da.23228. View

11.

Lau B, Tadrous M, Chu C, Hardcastle L, Beall R . COVID-19 and the prevalence of drug shortages in Canada: a cross-sectional time-series analysis from April 2017 to April 2022. CMAJ. 2022; 194(23):E801-E806. PMC: 9262135. DOI: 10.1503/cmaj.212070. View

12.

Vindegaard N, Benros M . COVID-19 pandemic and mental health consequences: Systematic review of the current evidence. Brain Behav Immun. 2020; 89:531-542. PMC: 7260522. DOI: 10.1016/j.bbi.2020.05.048. View

13.

Ark T, Kesselring S, Hills B, McGrail K . Population Data BC: Supporting population data science in British Columbia. Int J Popul Data Sci. 2020; 4(2):1133. PMC: 7480325. DOI: 10.23889/ijpds.v5i1.1133. View

14.

King L, Lovegrove M, Shehab N, Tsay S, Budnitz D, Geller A . Trends in US Outpatient Antibiotic Prescriptions During the Coronavirus Disease 2019 Pandemic. Clin Infect Dis. 2020; 73(3):e652-e660. PMC: 7799289. DOI: 10.1093/cid/ciaa1896. View

15.

Jandoc R, Burden A, Mamdani M, Levesque L, Cadarette S . Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol. 2015; 68(8):950-6. DOI: 10.1016/j.jclinepi.2014.12.018. View

16.

Piatek O, Ning J, Touchette D . National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages. Am J Health Syst Pharm. 2020; 77(21):1778-1785. PMC: 7454311. DOI: 10.1093/ajhp/zxaa228. View

17.

Campitelli M, Bronskill S, Maclagan L, Harris D, Cotton C, Tadrous M . Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021; 4(8):e2118441. PMC: 8329744. DOI: 10.1001/jamanetworkopen.2021.18441. View

18.

Grau S, Echeverria-Esnal D, Gomez-Zorrilla S, Navarrete-Rouco M, Masclans J, Espona M . Evolution of Antimicrobial Consumption During the First Wave of COVID-19 Pandemic. Antibiotics (Basel). 2021; 10(2). PMC: 7911440. DOI: 10.3390/antibiotics10020132. View

19.

Vaduganathan M, van Meijgaard J, Mehra M, Joseph J, ODonnell C, Warraich H . Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States. JAMA. 2020; 323(24):2524-2526. PMC: 7256862. DOI: 10.1001/jama.2020.9184. View

20.

Martin D, Miller A, Quesnel-Vallee A, Caron N, Vissandjee B, Marchildon G . Canada's universal health-care system: achieving its potential. Lancet. 2018; 391(10131):1718-1735. PMC: 7138369. DOI: 10.1016/S0140-6736(18)30181-8. View